| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 09/14/2005 | EP1572133A2 Method for identifying modulators of human orexin-2 receptor |
| 09/14/2005 | EP1572122A2 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides |
| 09/14/2005 | EP1572121A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 09/14/2005 | EP1572117A2 Production of ubiquinones |
| 09/14/2005 | EP1572116A2 Compositions and methods for the treatment of immune related diseases |
| 09/14/2005 | EP1572108A2 Functional mutations in respiratory syncytial virus |
| 09/14/2005 | EP1572106A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 09/14/2005 | EP1572102A2 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5 |
| 09/14/2005 | EP1572101A2 Disease treatment via antimicrobial peptide inhibitors |
| 09/14/2005 | EP1572100A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 09/14/2005 | EP1572099A2 Screening and therapeutic methods relating to neurogenesis |
| 09/14/2005 | EP1572098A2 Method of treating snoring and other obstructive breathing disorders |
| 09/14/2005 | EP1572097A2 Nucleoside derivatives for treating hepatitis c virus infection |
| 09/14/2005 | EP1572073A2 Alteration of rab38 function to modulate mammalian pigmentation |
| 09/14/2005 | EP1572067A2 Conjugates and compositions for cellular delivery |
| 09/14/2005 | EP1572064A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 09/14/2005 | CN1668592A Piperidine derivatives and their use as selective inhibitors of MIP-1alpha binding to its receptor CCR1 |
| 09/14/2005 | CN1668585A 3, 6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 09/14/2005 | CN1218940C Nitric oxide synthase inhibitors |
| 09/14/2005 | CN1218725C Medicament compsn. for curing acute pharyngitis and its preparation method |
| 09/13/2005 | US6943259 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 09/13/2005 | US6942870 For prevention of photodamage skin, for topical application |
| 09/13/2005 | US6942853 Latent fusion protein |
| 09/09/2005 | WO2005082383A1 A medical solution, a method for producing said medical solution and use thereof |
| 09/09/2005 | WO2005082378A1 A medical solution, a method for producing said medical solution and use thereof |
| 09/09/2005 | WO2005051286A3 Stable ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-yloxy) methyl)-2-amine-1h-purin-6(9h)-one. |
| 09/09/2005 | WO2005046614A3 System for treating and preventing breast cancer |
| 09/09/2005 | WO2005046611A3 Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| 09/09/2005 | WO2005046603A3 Pyridine compounds |
| 09/09/2005 | WO2005044192A3 Triazole compounds and uses related thereto |
| 09/09/2005 | WO2005044176A3 Compositions containing phosphatidic acid, methods of use thereof, methods of manufacture thereof, and articles of manufacture containing same |
| 09/09/2005 | WO2005037222A3 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 09/09/2005 | WO2005034851A3 Method and apparatus for providing uv light to blood |
| 09/09/2005 | WO2005032458A3 Dye solution and method for detecting anhydrous ammonia |
| 09/09/2005 | WO2005030151A3 Compounds and compositions as protein kinase inhibitors |
| 09/09/2005 | WO2005023175B1 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
| 09/09/2005 | WO2005018568A3 Inhibitors of cathepsin s |
| 09/09/2005 | WO2005011578A3 Preoperative treatment of post operative pain |
| 09/09/2005 | WO2005009386A3 Orally dissolving films |
| 09/09/2005 | WO2005009373A3 Tyrosine kinase inhibitors |
| 09/09/2005 | WO2005007122A3 Polymer stabilization |
| 09/09/2005 | WO2005007101A3 Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium |
| 09/09/2005 | WO2005007085A3 Pyrazolo pyrimidine derivatives and methods of use thereof |
| 09/09/2005 | WO2005002526A3 Method and compositions for treatment of viral infections |
| 09/09/2005 | WO2005000237B1 Granules containing biologically active substances |
| 09/09/2005 | WO2005000220A8 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| 09/09/2005 | WO2005000198A3 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
| 09/09/2005 | WO2004112691A3 Interferon gamma therapies for idiopathic pulmonary fibrosis |
| 09/09/2005 | WO2004110341A3 Antimicrobial and anticancer lipopeptides |
| 09/09/2005 | WO2004093822A3 Methods for predicting an individual's clinical treatment outcome from sampling a group of patients' biological profiles |
| 09/09/2005 | WO2004091484A3 Use of orsaponin [3beta, 16beta, 17 alpha-trihydroxycholost-5-en22-one 16-0-(2-0-4-methoxybenzoyl-beta-d-xylopyranosyl)-(1->3)-(2-0acetyl-alpha-l-arabinopyranoside)] or osw-1 and its derivatives for cancer therapeutics |
| 09/09/2005 | WO2004080371A3 Injectable isotonic solution of gatifloxacin pre-diluted in glucose. |
| 09/09/2005 | WO2004071455A3 In vitro prediction of sunscreen pfa values |
| 09/09/2005 | WO2004064777A3 Modified polysaccharides combination with anti-cancer drugs for enhanced treatment of cancer |
| 09/09/2005 | WO2004064762A3 Novel cocrystallization |
| 09/09/2005 | CA2548771A1 A medical solution, a method for producing said medical solution and use thereof |
| 09/09/2005 | CA2548770A1 A medical solution, a method for producing said medical solution and use thereof |
| 09/08/2005 | US20050198694 Truncated fragments of alpha-synuclein in Lewy body disease |
| 09/08/2005 | US20050197511 Reacting an acid and an amine; apoptosis; carbamate, and N-phenethyl-2-phenylacetamide |
| 09/08/2005 | US20050197501 Reacting calcium hydroxide with an ester derivative or protected ester derivative of the statin; rosuvastatin, pitavastatin and atorvastatin, simvastatin and lovastatin |
| 09/08/2005 | US20050197378 Cationic substituted benzofurans as antimicrobial agents |
| 09/08/2005 | US20050197371 Urea derivatives as PDGFR modulators |
| 09/08/2005 | US20050197349 Pyrrolo[2,3-D]pyrimidine compounds |
| 09/08/2005 | US20050197341 Reducing expression of tetrahydrobiopterin (BH4) biological activity; traumatic, metabolic or toxic peripheral nerve lesions |
| 09/08/2005 | US20050197327 Compounds, compositions, and methods |
| 09/08/2005 | US20050197326 1,4-benzothiazin-3-ones that are optionally S-mono- or dioxygenated, quinoxazinones, quinolinones and benzapinones; peptide deformylase inhibitors, used for treating bacterial infections |
| 09/08/2005 | US20050197306 DNA vaccines encoding heat shock proteins |
| 09/08/2005 | US20050197305 Methods and compositions for blocking progression of a disease state |
| 09/08/2005 | US20050197304 Stimulating regeneration with naked DNA encoding bioactive agents; does not cause insertional mutagenesis, host immunogenicity or tissues targeting difficulties |
| 09/08/2005 | US20050197299 Peptidomimetic protease inhibitors |
| 09/08/2005 | US20050196511 Containing natural xanthones derived from fruit of Garcinia mangostana plant; antioxidant medicinal effect |
| 09/08/2005 | US20050196477 Containing a protein derived from protein concentrates, isolates, or hydrolyzates, a xanthone derived from from the pericarp or the whole fruit , soluble fibers, vitamins and minerals; tablets, powders, capsules, solutions, syrups, elixirs, suspensions |
| 09/08/2005 | US20050196459 Carvedilol salts, anhydrates and/or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
| 09/08/2005 | US20050196440 Mucoadhesive drug delivery devices and methods of making and using thereof |
| 09/08/2005 | US20050196439 Process for co-spray drying agents with dry silicified MCC |
| 09/08/2005 | US20050196396 cancer therapy utilizing novel vascular endothelial cell growth factor receptor antagonists; immunoglobulin like domain from kinase domain receptor; nucleic acid encoding prolactin receptor antagonizing domain, a VEGF ligand and a cytokine; cell based assay; |
| 09/08/2005 | US20050196395 Methods of modulating immunity |
| 09/07/2005 | EP1570067A2 Methods and compositions for immunization against hiv |
| 09/07/2005 | EP1569942A2 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 09/07/2005 | EP1569937A2 C-6 modified indazolylpyrrolotriazines |
| 09/07/2005 | EP1569915A2 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 09/07/2005 | EP1569903A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
| 09/07/2005 | EP1569723A2 Nucleotide based medicament and method of use for treatment of conditions in humans |
| 09/07/2005 | EP1569686A2 Transmucosal administration of aggregated antigens |
| 09/07/2005 | EP1569680A2 Treatment of diabetes |
| 09/07/2005 | EP1569669A2 Withania somnifera composition, method for obtaining same and pharmaceutical, nutritional and personal care formulations thereof |
| 09/07/2005 | EP1569644A2 Indolizine compounds |
| 09/07/2005 | EP1569636A2 Use of equol for treating androgen mediated diseases |
| 09/07/2005 | EP1569597A2 Composition, especially a cosmetic composition, containing at least one alkyl para-hydroxybenzoate and at least one lipophilic amino acid derivative |
| 09/07/2005 | EP1569515A2 Methods for vaccinating against malaria |
| 09/07/2005 | EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 09/07/2005 | EP1335740B1 Preparations having effect against allergic symptoms and their manufacturing method |
| 09/07/2005 | EP1013278B1 The extract of pine needle and the use thereof |
| 09/07/2005 | EP0981326B1 Personal cleansing compositions |
| 09/07/2005 | CN1665815A Novel tetracyclo-aryl-carbonyl indoles used as therapeutical agents with 5-hydroxy-tryptamine receptor affinity, their preparation process and pharmaceutical compounds containing same |
| 09/07/2005 | CN1665809A Azaindoles |
| 09/07/2005 | CN1665488A Direct cellular energy delivery system |
| 09/07/2005 | CN1665458A Injectable chondrocyte implant |
| 09/07/2005 | CN1217918C Aminocyclohexyl ether compounds and uses thereof |
| 09/07/2005 | CN1217659C Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |